Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
232 studies found for:    Open Studies | "Macular Degeneration"
Show Display Options
Rank Status Study
21 Recruiting Study of Photobiomodulation to Treat Dry Age-Related Macular Degeneration
Condition: Age Related Macular Degeneration
Interventions: Device: LT-300 Active (PBM);   Device: LT-300 Inactive (Sham)
22 Recruiting Comparison of Pharmacokinetics of and Effect on Systemic VEGF Levels in Age Related Macular Degeneration Patients
Condition: Age Related Macular Degeneration
Interventions: Drug: Ranibizumab;   Drug: Bevacizumab;   Drug: Aflibercept;   Other: Control Group
23 Recruiting An Open-Label, Phase 1 Clinical Study to Evaluate the Safety and Tolerability of Subcutaneous Elamipretide in Subjects With Intermediate Age-Related Macular Degeneration
Condition: Age-Related Macular Degeneration
Intervention: Drug: Elamipretide
24 Recruiting Systemic VEGF Protein Dynamics Following Intravitreal Injections of Ranibizumab Versus Aflibercept in Patients With Neovascular Age-related Macular Degeneration
Condition: Age-Related Macular Degeneration
Interventions: Drug: Ranibizumab;   Drug: Aflibercept
25 Recruiting Natural History of Geographic Atrophy Associated With Age-Related Macular Degeneration
Condition: Age-Related Macular Degeneration
Intervention:
26 Not yet recruiting A Study to Compare SB11 (Proposed Ranibizumab Biosimilar) to Lucentis in Subjects With Neovascular Age-related Macular Degeneration (AMD)
Condition: Age-Related Macular Degeneration
Interventions: Drug: SB11 (Proposed ranibizumab biosimilar);   Drug: Lucentis (ranibizumab)
27 Recruiting Treatment of Dry Age Related Macular Degeneration Disease With Retinal Pigment Epithelium Derived From Human Embryonic Stem Cells
Condition: Dry Age-related Macular Degeneration
Intervention: Biological: retinal pigment epithelium transplantation
28 Recruiting Subretinal Transplantation of Retinal Pigment Epitheliums in Treatment of Age-related Macular Degeneration Diseases
Condition: Dry Age-related Macular Degeneration
Intervention: Biological: retinal pigment epithelium transplantation
29 Recruiting Functional and Structural Outcomes in Neovascular Age-related Macular Degeneration
Condition: Neovascular Age-related Macular Degeneration
Intervention: Drug: Ranibizumab
30 Recruiting Efficacy and Safety of the Biosimilar Ranibizumab FYB201 in Comparison to Lucentis in Patients With Neovascular Age-related Macular Degeneration
Condition: Age-related Macular Degeneration (AMD)
Intervention: Biological: ranibizumab
31 Recruiting Evaluation of Oral Minocycline in the Treatment of Geographic Atrophy Associated With Age-Related Macular Degeneration
Condition: Age- Related Macular Degeneration
Interventions: Drug: Minocycline;   Other: Placebo
32 Recruiting Treatment of Advanced Dry Age Related Macular Degeneration With AAVCAGsCD59
Condition: Dry Age-related Macular Degeneration
Intervention: Biological: AAVCAGsCD59
33 Recruiting Safety and Efficacy Study of OpRegen for Treatment of Advanced Dry-Form Age-Related Macular Degeneration
Condition: Age-related Macular Degeneration
Intervention: Biological: OpRegen
34 Not yet recruiting Efficacy of Biweekly Ranibizumab (0.5 mg) for Exudative Macular Degeneration Retinal Edema Refractory to Anti-VEGF
Condition: Exudative Age Related Macular Degeneration
Intervention: Drug: Ranibizumab Injection [Lucentis]
35 Recruiting Evaluation of the Protective Role of the L-DOPA Against Age Related Macular Degeneration in Parkinson's Patients
Condition: Macular Degeneration, Senile
Interventions: Device: Color retinography;   Device: Optical coherence tomography;   Device: Fundus autofluorescence imaging
36 Recruiting Association of Previously Verified Gene Polymorphisms With AMD in Turkish Population
Condition: Age-related Macular Degeneration
Intervention:
37 Recruiting Intravitreal tPA and C3F8 for the Treatment of Submacular Haemorrhage as a Complication of Neovascular Age-related Macular Degeneration
Conditions: Exudative Macular Degeneration;   Retinal Hemorrhage
Interventions: Drug: Ranibizumab;   Drug: C3F8 Gas;   Drug: tPA
38 Recruiting Cohort Study on the Age-related Macular Degeneration: Incidence and Research for Predisposing Factors
Conditions: Elderly French Population;   Age-related Macular Degeneration
Interventions: Other: clinical parameters;   Other: visual acuity exams;   Other: retinophotography;   Other: SD-OCT;   Other: Intra ocular Pressure (IOP);   Other: retinal imaging (OPTOMAP);   Other: axial length (IOL master)
39 Recruiting AVENUE: A Proof-of-Concept Study of RG7716 in Participants With Choroidal Neovascularization (CNV) Secondary to Age-Related Macular Degeneration (AMD)
Condition: Macular Degeneration, Choroidal Neovascularization
Interventions: Drug: RG7716;   Drug: Ranibizumab
40 Recruiting Deficits, Adaptation and Cerebral Functional Reorganization of Visual Retinotopic Treatments During Normal and Pathological Aging (Age-related Macular Degeneration and Glaucoma)
Conditions: Macular Degeneration;   Glaucoma
Intervention: Radiation: Functional Magnetic Resonance Imaging (fMRI)

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.